ADCYAP1 and retinoblastoma: In our study, we described, for the first time, the distribution of PACAP38 and PAC1R immunoreactivity in human retinoblastoma and we confirmed the cytotoxic effect of micromolar PACAP38 concentrations in human retinoblastoma cells.